---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-035753"
form_type: "8-K"
ticker: "BFRG"
cik: "0001829247"
company_name: "BullFrog AI Holdings, Inc."
filed_at: "2023-10-05T23:59:59+00:00"
generated_at: "2026-06-10T04:09:21.439448+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bullfrog AI identifies 3 novel colorectal cancer targets via bfLEAP platform; validation with JCVI planned

## Summary
- 14 candidates over-expressed in colon tumors identified using TCGA data; 3 are novel, 6 near-novel.
- bfLEAP platform reduced candidate list from >3,000 traditional analysis to 14 actionable targets.
- Target validation to be conducted with J. Craig Venter Institute under existing collaboration.
- Colorectal cancer market valued at $11.5B in 2022, projected CAGR 4.7% through 2030.

## SEC filing metadata
- accession: 0001493152-23-035753
- form_type: 8-K
- ticker: BFRG
- cik: 0001829247
- company_name: BullFrog AI Holdings, Inc.
- filed_at: 2023-10-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829247/000149315223035753/0001493152-23-035753-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829247/000149315223035753/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-035753
- JSON: https://secwatch.observer/filing/0001493152-23-035753.json
- Plain text: https://secwatch.observer/filing/0001493152-23-035753.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.